Statistics

Number of Journals8
Number of Issues52
Number of Articles379
Article View107,119
PDF Download71,333
Andishmand, A., Seyed Hossaini Tezerjani, S., Haghaninejad, H., Amel Shahbaz, S., Mousavi Nodoushan, S. (2025). Evaluating the limited impact of therapy with empagliflozin on primary PCI patients' outcomes: the ELITE-PCI trial. Shahid Sadoughi University of Medical Sciences- Journal Management System, 5(1), 52-60. doi: 10.18502/cbj.v5i1.19452
Abbas Andishmand; Seyed Mostafa Seyed Hossaini Tezerjani; Hasan Haghaninejad; Sara Amel Shahbaz; Seyed Mostafa Mousavi Nodoushan. "Evaluating the limited impact of therapy with empagliflozin on primary PCI patients' outcomes: the ELITE-PCI trial". Shahid Sadoughi University of Medical Sciences- Journal Management System, 5, 1, 2025, 52-60. doi: 10.18502/cbj.v5i1.19452
Andishmand, A., Seyed Hossaini Tezerjani, S., Haghaninejad, H., Amel Shahbaz, S., Mousavi Nodoushan, S. (2025). 'Evaluating the limited impact of therapy with empagliflozin on primary PCI patients' outcomes: the ELITE-PCI trial', Shahid Sadoughi University of Medical Sciences- Journal Management System, 5(1), pp. 52-60. doi: 10.18502/cbj.v5i1.19452
Andishmand, A., Seyed Hossaini Tezerjani, S., Haghaninejad, H., Amel Shahbaz, S., Mousavi Nodoushan, S. Evaluating the limited impact of therapy with empagliflozin on primary PCI patients' outcomes: the ELITE-PCI trial. Shahid Sadoughi University of Medical Sciences- Journal Management System, 2025; 5(1): 52-60. doi: 10.18502/cbj.v5i1.19452


Journal Management System. Powered by Sinaweb